

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.64090010 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.64090010 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.39493379 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.39493379 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.90367502 |
| 6 | glyoxylate metabolic process (GO:0046487) | 6.31119784 |
| 7 | tryptophan catabolic process (GO:0006569) | 6.25125629 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.25125629 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.25125629 |
| 10 | cysteine metabolic process (GO:0006534) | 6.06350385 |
| 11 | tryptophan metabolic process (GO:0006568) | 5.92473094 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.89311248 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.78852181 |
| 14 | lysine metabolic process (GO:0006553) | 5.57080456 |
| 15 | lysine catabolic process (GO:0006554) | 5.57080456 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.55244901 |
| 17 | serine family amino acid catabolic process (GO:0009071) | 5.46349128 |
| 18 | sulfur amino acid catabolic process (GO:0000098) | 5.45289799 |
| 19 | urea metabolic process (GO:0019627) | 5.37176155 |
| 20 | urea cycle (GO:0000050) | 5.37176155 |
| 21 | epoxygenase P450 pathway (GO:0019373) | 5.16902794 |
| 22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.11821758 |
| 23 | alpha-linolenic acid metabolic process (GO:0036109) | 5.10953852 |
| 24 | aromatic amino acid family metabolic process (GO:0009072) | 5.06295784 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 4.99888945 |
| 26 | negative regulation of fibrinolysis (GO:0051918) | 4.97183532 |
| 27 | homocysteine metabolic process (GO:0050667) | 4.96831486 |
| 28 | high-density lipoprotein particle remodeling (GO:0034375) | 4.88952921 |
| 29 | bile acid metabolic process (GO:0008206) | 4.88794014 |
| 30 | amino-acid betaine metabolic process (GO:0006577) | 4.86354274 |
| 31 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.83935318 |
| 32 | protein carboxylation (GO:0018214) | 4.83935318 |
| 33 | alpha-amino acid catabolic process (GO:1901606) | 4.79267425 |
| 34 | urate metabolic process (GO:0046415) | 4.78228313 |
| 35 | regulation of fibrinolysis (GO:0051917) | 4.76529607 |
| 36 | serine family amino acid metabolic process (GO:0009069) | 4.74293526 |
| 37 | drug catabolic process (GO:0042737) | 4.71366844 |
| 38 | complement activation, alternative pathway (GO:0006957) | 4.69517488 |
| 39 | cellular ketone body metabolic process (GO:0046950) | 4.69159662 |
| 40 | regulation of protein activation cascade (GO:2000257) | 4.67458385 |
| 41 | blood coagulation, intrinsic pathway (GO:0007597) | 4.63747155 |
| 42 | glycine metabolic process (GO:0006544) | 4.63605374 |
| 43 | tyrosine metabolic process (GO:0006570) | 4.62655679 |
| 44 | drug transmembrane transport (GO:0006855) | 4.57817388 |
| 45 | serine family amino acid biosynthetic process (GO:0009070) | 4.56476292 |
| 46 | cellular amino acid catabolic process (GO:0009063) | 4.49604149 |
| 47 | indolalkylamine metabolic process (GO:0006586) | 4.46653371 |
| 48 | cellular modified amino acid catabolic process (GO:0042219) | 4.37938653 |
| 49 | regulation of complement activation (GO:0030449) | 4.36372869 |
| 50 | coenzyme catabolic process (GO:0009109) | 4.35508242 |
| 51 | omega-hydroxylase P450 pathway (GO:0097267) | 4.35430185 |
| 52 | cellular biogenic amine catabolic process (GO:0042402) | 4.34321510 |
| 53 | amine catabolic process (GO:0009310) | 4.34321510 |
| 54 | oxidative demethylation (GO:0070989) | 4.29925345 |
| 55 | regulation of triglyceride catabolic process (GO:0010896) | 4.29593777 |
| 56 | regulation of cholesterol esterification (GO:0010872) | 4.28325393 |
| 57 | benzene-containing compound metabolic process (GO:0042537) | 4.25227319 |
| 58 | glutamate metabolic process (GO:0006536) | 4.23781886 |
| 59 | triglyceride homeostasis (GO:0070328) | 4.20318482 |
| 60 | acylglycerol homeostasis (GO:0055090) | 4.20318482 |
| 61 | negative regulation of cholesterol transport (GO:0032375) | 4.20263282 |
| 62 | negative regulation of sterol transport (GO:0032372) | 4.20263282 |
| 63 | cellular glucuronidation (GO:0052695) | 4.20153914 |
| 64 | aldehyde catabolic process (GO:0046185) | 4.19374854 |
| 65 | short-chain fatty acid metabolic process (GO:0046459) | 4.18594578 |
| 66 | reverse cholesterol transport (GO:0043691) | 4.16559344 |
| 67 | exogenous drug catabolic process (GO:0042738) | 4.14759584 |
| 68 | plasma lipoprotein particle remodeling (GO:0034369) | 4.14608873 |
| 69 | protein-lipid complex remodeling (GO:0034368) | 4.14608873 |
| 70 | macromolecular complex remodeling (GO:0034367) | 4.14608873 |
| 71 | ethanol oxidation (GO:0006069) | 4.13909172 |
| 72 | intestinal cholesterol absorption (GO:0030299) | 4.10300863 |
| 73 | aspartate family amino acid catabolic process (GO:0009068) | 4.08064704 |
| 74 | bile acid and bile salt transport (GO:0015721) | 4.06458163 |
| 75 | ketone body metabolic process (GO:1902224) | 4.05204384 |
| 76 | imidazole-containing compound metabolic process (GO:0052803) | 4.03176326 |
| 77 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.01593095 |
| 78 | phenylpropanoid metabolic process (GO:0009698) | 3.99554260 |
| 79 | ethanol metabolic process (GO:0006067) | 3.99312707 |
| 80 | organic acid catabolic process (GO:0016054) | 3.95595563 |
| 81 | carboxylic acid catabolic process (GO:0046395) | 3.95595563 |
| 82 | acetyl-CoA metabolic process (GO:0006084) | 3.90939855 |
| 83 | phospholipid efflux (GO:0033700) | 3.88718068 |
| 84 | arginine metabolic process (GO:0006525) | 3.87592911 |
| 85 | drug transport (GO:0015893) | 3.85520836 |
| 86 | glucuronate metabolic process (GO:0019585) | 3.81532240 |
| 87 | uronic acid metabolic process (GO:0006063) | 3.81532240 |
| 88 | plasma lipoprotein particle clearance (GO:0034381) | 3.80694646 |
| 89 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.73654256 |
| 90 | 2-oxoglutarate metabolic process (GO:0006103) | 3.69429596 |
| 91 | fatty acid beta-oxidation (GO:0006635) | 3.68124804 |
| 92 | low-density lipoprotein particle remodeling (GO:0034374) | 3.67344217 |
| 93 | cofactor catabolic process (GO:0051187) | 3.66358141 |
| 94 | carnitine metabolic process (GO:0009437) | 3.66006847 |
| 95 | fatty acid oxidation (GO:0019395) | 3.65939704 |
| 96 | drug metabolic process (GO:0017144) | 3.65235044 |
| 97 | monocarboxylic acid catabolic process (GO:0072329) | 3.62847268 |
| 98 | valine metabolic process (GO:0006573) | 3.58151778 |
| 99 | lipid oxidation (GO:0034440) | 3.58119827 |
| 100 | regulation of bile acid biosynthetic process (GO:0070857) | 3.57870520 |
| 101 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.57512087 |
| 102 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.57512087 |
| 103 | negative regulation of protein activation cascade (GO:2000258) | 3.57317832 |
| 104 | fibrinolysis (GO:0042730) | 3.56847079 |
| 105 | cholesterol efflux (GO:0033344) | 3.55393522 |
| 106 | response to nitrosative stress (GO:0051409) | 3.54274735 |
| 107 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.52413020 |
| 108 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.52413020 |
| 109 | NAD biosynthetic process (GO:0009435) | 3.51889736 |
| 110 | plasma lipoprotein particle organization (GO:0071827) | 3.51132355 |
| 111 | fatty acid catabolic process (GO:0009062) | 3.50756278 |
| 112 | flavonoid metabolic process (GO:0009812) | 3.50165475 |
| 113 | S-adenosylmethionine metabolic process (GO:0046500) | 3.49013498 |
| 114 | plasma lipoprotein particle assembly (GO:0034377) | 3.47979457 |
| 115 | regulation of cholesterol homeostasis (GO:2000188) | 3.47968573 |
| 116 | phospholipid homeostasis (GO:0055091) | 3.47602005 |
| 117 | regulation of plasminogen activation (GO:0010755) | 3.44263134 |
| 118 | negative regulation of lipase activity (GO:0060192) | 3.40527811 |
| 119 | heme transport (GO:0015886) | 3.36147189 |
| 120 | diacylglycerol metabolic process (GO:0046339) | 3.27768304 |
| 121 | cholesterol homeostasis (GO:0042632) | 3.27563084 |
| 122 | cytolysis (GO:0019835) | 3.27234628 |
| 123 | sterol homeostasis (GO:0055092) | 3.20593862 |
| 124 | protein activation cascade (GO:0072376) | 3.19803734 |
| 125 | alkaloid metabolic process (GO:0009820) | 3.16813421 |
| 126 | peptidyl-glutamic acid modification (GO:0018200) | 3.14436944 |
| 127 | polyketide metabolic process (GO:0030638) | 3.13944873 |
| 128 | doxorubicin metabolic process (GO:0044598) | 3.13944873 |
| 129 | daunorubicin metabolic process (GO:0044597) | 3.13944873 |
| 130 | protein-lipid complex subunit organization (GO:0071825) | 3.13372206 |
| 131 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.12410165 |
| 132 | acute-phase response (GO:0006953) | 3.11334513 |
| 133 | regulation of humoral immune response (GO:0002920) | 3.10640646 |
| 134 | regulation of lipoprotein particle clearance (GO:0010984) | 3.10270547 |
| 135 | glycerol metabolic process (GO:0006071) | 3.08781563 |
| 136 | negative regulation of blood coagulation (GO:0030195) | 3.07841587 |
| 137 | negative regulation of hemostasis (GO:1900047) | 3.07841587 |
| 138 | negative regulation of complement activation (GO:0045916) | 3.05683063 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.27002670 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.09910155 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.90745551 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.21495497 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.10528900 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.88153402 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.85162896 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.29446363 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.64538673 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.75646473 |
| 11 | VDR_22108803_ChIP-Seq_LS180_Human | 2.71397397 |
| 12 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.66312375 |
| 13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.42060540 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.41729313 |
| 15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.39585239 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.28215937 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7435772 |
| 18 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.98253179 |
| 19 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.93762494 |
| 20 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.83769326 |
| 21 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.79808194 |
| 22 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.72931471 |
| 23 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.69014049 |
| 24 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.60523527 |
| 25 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.60240132 |
| 26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.56908021 |
| 27 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.55970982 |
| 28 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.50463356 |
| 29 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.49704471 |
| 30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.47426496 |
| 31 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.46716947 |
| 32 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.45845087 |
| 33 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.45589187 |
| 34 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.44118100 |
| 35 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.42853215 |
| 36 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.42408452 |
| 37 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.38266412 |
| 38 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.38266412 |
| 39 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.37883966 |
| 40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.37544773 |
| 41 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.36241461 |
| 42 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.36239210 |
| 43 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.35473900 |
| 44 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.35312810 |
| 45 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.33866938 |
| 46 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.31795138 |
| 47 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.30931015 |
| 48 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.30931015 |
| 49 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.28281680 |
| 50 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.26197738 |
| 51 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.25102097 |
| 52 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.24538760 |
| 53 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.21081976 |
| 54 | P300_19829295_ChIP-Seq_ESCs_Human | 1.20384593 |
| 55 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.19290619 |
| 56 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.19290619 |
| 57 | GATA1_22025678_ChIP-Seq_K562_Human | 1.17966613 |
| 58 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.17791607 |
| 59 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.17699748 |
| 60 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.17433442 |
| 61 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.16368883 |
| 62 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.15645485 |
| 63 | FUS_26573619_Chip-Seq_HEK293_Human | 1.15512497 |
| 64 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.14922283 |
| 65 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.14435712 |
| 66 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.12640922 |
| 67 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.12482001 |
| 68 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.11823719 |
| 69 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.11386007 |
| 70 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.11200551 |
| 71 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.09647610 |
| 72 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.09446585 |
| 73 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04983422 |
| 74 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.03563519 |
| 75 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.02473352 |
| 76 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01849781 |
| 77 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.00204924 |
| 78 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.99977879 |
| 79 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98689687 |
| 80 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.98660362 |
| 81 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.98102446 |
| 82 | STAT3_23295773_ChIP-Seq_U87_Human | 0.97531982 |
| 83 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96583871 |
| 84 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.95784910 |
| 85 | ERA_21632823_ChIP-Seq_H3396_Human | 0.95538922 |
| 86 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.95237780 |
| 87 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.93872815 |
| 88 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.93488199 |
| 89 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92759940 |
| 90 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.92428016 |
| 91 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.91539753 |
| 92 | * MYC_19829295_ChIP-Seq_ESCs_Human | 0.91276801 |
| 93 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.90786440 |
| 94 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.90138883 |
| 95 | AR_25329375_ChIP-Seq_VCAP_Human | 0.89207808 |
| 96 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.88828039 |
| 97 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.88087332 |
| 98 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.87889131 |
| 99 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.87096421 |
| 100 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.86485768 |
| 101 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.86049813 |
| 102 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.86048211 |
| 103 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.83748750 |
| 104 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.83298991 |
| 105 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.77951782 |
| 106 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.77524184 |
| 107 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.77370397 |
| 108 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.74567454 |
| 109 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.73351624 |
| 110 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.72648606 |
| 111 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.67936653 |
| 112 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.66988686 |
| 113 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.66402999 |
| 114 | AR_20517297_ChIP-Seq_VCAP_Human | 0.66230775 |
| 115 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.65567192 |
| 116 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.65561034 |
| 117 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.65421565 |
| 118 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.65374614 |
| 119 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.64643147 |
| 120 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.64307000 |
| 121 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63325323 |
| 122 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.62831827 |
| 123 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.62380398 |
| 124 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.62271188 |
| 125 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.61197794 |
| 126 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.60564091 |
| 127 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.59537353 |
| 128 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.56430120 |
| 129 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.55872079 |
| 130 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.55742301 |
| 131 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.55129099 |
| 132 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.54783081 |
| 133 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.51669889 |
| 134 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.51307801 |
| 135 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.50532418 |
| 136 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.50460910 |
| 137 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.50359935 |
| 138 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.48414391 |
| 139 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.47900456 |
| 140 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.47468001 |
| 141 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.47462642 |
| 142 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.46874899 |
| 143 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46798829 |
| 144 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.46615897 |
| 145 | CBP_21632823_ChIP-Seq_H3396_Human | 0.45797595 |
| 146 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.45610789 |
| 147 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.45116551 |
| 148 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.43799637 |
| 149 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.43230261 |
| 150 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.43060714 |
| 151 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.42165301 |
| 152 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.41935666 |
| 153 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.41457004 |
| 154 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.41378680 |
| 155 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.39587441 |
| 156 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.39388217 |
| 157 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.39274324 |
| 158 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.39178645 |
| 159 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.39005570 |
| 160 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.38244641 |
| 161 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.37784072 |
| 162 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.37696347 |
| 163 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.37495700 |
| 164 | NCOR_22424771_ChIP-Seq_293T_Human | 0.37338580 |
| 165 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.37214156 |
| 166 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.36873023 |
| 167 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.36818765 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.23587015 |
| 2 | MP0005360_urolithiasis | 7.86143136 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.07390178 |
| 4 | MP0005365_abnormal_bile_salt | 5.94230187 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.00431589 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.43831277 |
| 7 | MP0003252_abnormal_bile_duct | 3.69792432 |
| 8 | MP0005332_abnormal_amino_acid | 3.25330233 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.16401253 |
| 10 | MP0003195_calcinosis | 3.09746660 |
| 11 | MP0009840_abnormal_foam_cell | 2.91898843 |
| 12 | MP0005083_abnormal_biliary_tract | 2.83393741 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.59845966 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.55531003 |
| 15 | MP0003122_maternal_imprinting | 2.24711160 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.23155444 |
| 17 | MP0000609_abnormal_liver_physiology | 2.01647385 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.01568527 |
| 19 | MP0006292_abnormal_olfactory_placode | 1.97392457 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.95674747 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.86004463 |
| 22 | MP0005451_abnormal_body_composition | 1.85557603 |
| 23 | MP0001764_abnormal_homeostasis | 1.82238328 |
| 24 | MP0009643_abnormal_urine_homeostasis | 1.75381584 |
| 25 | MP0003868_abnormal_feces_composition | 1.73795141 |
| 26 | MP0003186_abnormal_redox_activity | 1.70343046 |
| 27 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59915931 |
| 28 | MP0009697_abnormal_copulation | 1.45271296 |
| 29 | MP0005551_abnormal_eye_electrophysiolog | 1.38772027 |
| 30 | MP0005636_abnormal_mineral_homeostasis | 1.38335135 |
| 31 | MP0005379_endocrine/exocrine_gland_phen | 1.20717468 |
| 32 | MP0008877_abnormal_DNA_methylation | 1.20326989 |
| 33 | MP0003656_abnormal_erythrocyte_physiolo | 1.17755592 |
| 34 | MP0006036_abnormal_mitochondrial_physio | 1.17677192 |
| 35 | MP0000598_abnormal_liver_morphology | 1.17337106 |
| 36 | MP0004043_abnormal_pH_regulation | 1.14336403 |
| 37 | MP0003011_delayed_dark_adaptation | 1.13015142 |
| 38 | MP0002938_white_spotting | 1.12690518 |
| 39 | MP0003136_yellow_coat_color | 1.11681165 |
| 40 | MP0005408_hypopigmentation | 1.09310601 |
| 41 | MP0003121_genomic_imprinting | 1.09185745 |
| 42 | MP0003718_maternal_effect | 1.07832585 |
| 43 | MP0005647_abnormal_sex_gland | 1.06092000 |
| 44 | MP0002638_abnormal_pupillary_reflex | 1.05820995 |
| 45 | MP0001986_abnormal_taste_sensitivity | 1.04419090 |
| 46 | MP0005220_abnormal_exocrine_pancreas | 1.02744480 |
| 47 | MP0004142_abnormal_muscle_tone | 1.00978716 |
| 48 | MP0005084_abnormal_gallbladder_morpholo | 0.99794935 |
| 49 | MP0001756_abnormal_urination | 0.98142997 |
| 50 | MP0001324_abnormal_eye_pigmentation | 0.97676469 |
| 51 | MP0009763_increased_sensitivity_to | 0.92637797 |
| 52 | MP0009764_decreased_sensitivity_to | 0.92629381 |
| 53 | MP0002132_abnormal_respiratory_system | 0.91247362 |
| 54 | MP0009642_abnormal_blood_homeostasis | 0.89477917 |
| 55 | MP0003705_abnormal_hypodermis_morpholog | 0.88400595 |
| 56 | MP0008469_abnormal_protein_level | 0.87057249 |
| 57 | MP0005670_abnormal_white_adipose | 0.86967063 |
| 58 | MP0000372_irregular_coat_pigmentation | 0.86782205 |
| 59 | MP0002876_abnormal_thyroid_physiology | 0.83419114 |
| 60 | MP0002136_abnormal_kidney_physiology | 0.83026859 |
| 61 | MP0002909_abnormal_adrenal_gland | 0.82258567 |
| 62 | MP0005376_homeostasis/metabolism_phenot | 0.79607984 |
| 63 | MP0000604_amyloidosis | 0.78792056 |
| 64 | MP0005645_abnormal_hypothalamus_physiol | 0.78637994 |
| 65 | MP0002078_abnormal_glucose_homeostasis | 0.78526763 |
| 66 | MP0005395_other_phenotype | 0.77123476 |
| 67 | MP0008789_abnormal_olfactory_epithelium | 0.77033630 |
| 68 | MP0004133_heterotaxia | 0.76653691 |
| 69 | MP0003878_abnormal_ear_physiology | 0.76143579 |
| 70 | MP0005377_hearing/vestibular/ear_phenot | 0.76143579 |
| 71 | MP0002163_abnormal_gland_morphology | 0.74671404 |
| 72 | MP0009765_abnormal_xenobiotic_induced | 0.74553815 |
| 73 | MP0010368_abnormal_lymphatic_system | 0.74295234 |
| 74 | MP0005266_abnormal_metabolism | 0.71133011 |
| 75 | MP0005410_abnormal_fertilization | 0.70296883 |
| 76 | MP0001765_abnormal_ion_homeostasis | 0.69936192 |
| 77 | MP0001661_extended_life_span | 0.69118544 |
| 78 | MP0006276_abnormal_autonomic_nervous | 0.69063469 |
| 79 | MP0001984_abnormal_olfaction | 0.68662409 |
| 80 | MP0005535_abnormal_body_temperature | 0.68543098 |
| 81 | MP0006035_abnormal_mitochondrial_morpho | 0.64629367 |
| 82 | MP0005195_abnormal_posterior_eye | 0.64616242 |
| 83 | MP0001529_abnormal_vocalization | 0.63836892 |
| 84 | MP0003950_abnormal_plasma_membrane | 0.63598762 |
| 85 | MP0001293_anophthalmia | 0.63212859 |
| 86 | MP0000566_synostosis | 0.63137278 |
| 87 | MP0003787_abnormal_imprinting | 0.61653107 |
| 88 | MP0002971_abnormal_brown_adipose | 0.60144428 |
| 89 | MP0003879_abnormal_hair_cell | 0.58389640 |
| 90 | MP0005334_abnormal_fat_pad | 0.57984155 |
| 91 | MP0005253_abnormal_eye_physiology | 0.57282463 |
| 92 | MP0000639_abnormal_adrenal_gland | 0.56932129 |
| 93 | MP0005075_abnormal_melanosome_morpholog | 0.55784942 |
| 94 | MP0002160_abnormal_reproductive_system | 0.55641454 |
| 95 | MP0001968_abnormal_touch/_nociception | 0.55492066 |
| 96 | MP0005389_reproductive_system_phenotype | 0.54914156 |
| 97 | MP0002736_abnormal_nociception_after | 0.54306273 |
| 98 | MP0005058_abnormal_lysosome_morphology | 0.53944767 |
| 99 | MP0002928_abnormal_bile_duct | 0.53109460 |
| 100 | MP0002102_abnormal_ear_morphology | 0.51880626 |
| 101 | MP0009053_abnormal_anal_canal | 0.51050207 |
| 102 | MP0002254_reproductive_system_inflammat | 0.50594889 |
| 103 | MP0005167_abnormal_blood-brain_barrier | 0.49732314 |
| 104 | MP0005646_abnormal_pituitary_gland | 0.49410512 |
| 105 | MP0004264_abnormal_extraembryonic_tissu | 0.48982493 |
| 106 | MP0003638_abnormal_response/metabolism_ | 0.48231547 |
| 107 | MP0001485_abnormal_pinna_reflex | 0.47781323 |
| 108 | MP0002090_abnormal_vision | 0.47615824 |
| 109 | MP0003329_amyloid_beta_deposits | 0.47351976 |
| 110 | MP0004782_abnormal_surfactant_physiolog | 0.46485998 |
| 111 | MP0002277_abnormal_respiratory_mucosa | 0.46356772 |
| 112 | MP0003698_abnormal_male_reproductive | 0.45151265 |
| 113 | MP0001501_abnormal_sleep_pattern | 0.44908869 |
| 114 | MP0003953_abnormal_hormone_level | 0.44794888 |
| 115 | MP0008873_increased_physiological_sensi | 0.43864270 |
| 116 | MP0009672_abnormal_birth_weight | 0.41721762 |
| 117 | MP0000230_abnormal_systemic_arterial | 0.40902412 |
| 118 | MP0005666_abnormal_adipose_tissue | 0.40612921 |
| 119 | MP0004130_abnormal_muscle_cell | 0.39750067 |
| 120 | MP0002168_other_aberrant_phenotype | 0.38737529 |
| 121 | MP0000538_abnormal_urinary_bladder | 0.38697839 |
| 122 | MP0005448_abnormal_energy_balance | 0.38609857 |
| 123 | MP0002135_abnormal_kidney_morphology | 0.38319821 |
| 124 | MP0003699_abnormal_female_reproductive | 0.37842938 |
| 125 | MP0003724_increased_susceptibility_to | 0.36694213 |
| 126 | MP0008872_abnormal_physiological_respon | 0.36145129 |
| 127 | MP0000579_abnormal_nail_morphology | 0.36111548 |
| 128 | MP0003646_muscle_fatigue | 0.35417173 |
| 129 | MP0002837_dystrophic_cardiac_calcinosis | 0.35062406 |
| 130 | MP0005464_abnormal_platelet_physiology | 0.33625143 |
| 131 | MP0001944_abnormal_pancreas_morphology | 0.32166188 |
| 132 | MP0003690_abnormal_glial_cell | 0.31886947 |
| 133 | MP0008874_decreased_physiological_sensi | 0.30967969 |
| 134 | MP0002970_abnormal_white_adipose | 0.30695293 |
| 135 | MP0002796_impaired_skin_barrier | 0.29848985 |
| 136 | MP0001119_abnormal_female_reproductive | 0.28965658 |
| 137 | MP0001845_abnormal_inflammatory_respons | 0.27595517 |
| 138 | MP0009384_cardiac_valve_regurgitation | 0.27206926 |
| 139 | MP0004147_increased_porphyrin_level | 0.26420245 |
| 140 | MP0009115_abnormal_fat_cell | 0.25886353 |
| 141 | MP0005166_decreased_susceptibility_to | 0.24800753 |
| 142 | MP0002269_muscular_atrophy | 0.24619642 |
| 143 | MP0003436_decreased_susceptibility_to | 0.23314498 |
| 144 | MP0003075_altered_response_to | 0.21980490 |
| 145 | MP0003959_abnormal_lean_body | 0.21552436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.22409379 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.77080903 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.37659507 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.11615947 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 5.66188628 |
| 6 | Xanthomatosis (HP:0000991) | 5.64444116 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.53160674 |
| 8 | Hyperglycinemia (HP:0002154) | 4.72890898 |
| 9 | Hyperglycinuria (HP:0003108) | 4.72123378 |
| 10 | Hyperammonemia (HP:0001987) | 4.70969514 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 4.68378535 |
| 12 | Ketosis (HP:0001946) | 4.62716133 |
| 13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.56416715 |
| 14 | Abnormality of glycine metabolism (HP:0010895) | 4.46745177 |
| 15 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.46745177 |
| 16 | Complement deficiency (HP:0004431) | 4.45090284 |
| 17 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.39971923 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.31569859 |
| 19 | Hypolipoproteinemia (HP:0010981) | 4.12873912 |
| 20 | Joint hemorrhage (HP:0005261) | 4.07477385 |
| 21 | Abnormality of methionine metabolism (HP:0010901) | 4.05407928 |
| 22 | Fat malabsorption (HP:0002630) | 3.94585413 |
| 23 | Hypoglycemic coma (HP:0001325) | 3.93727331 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 3.85331389 |
| 25 | Gout (HP:0001997) | 3.83128867 |
| 26 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.82333332 |
| 27 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.77562481 |
| 28 | Epidermoid cyst (HP:0200040) | 3.76892725 |
| 29 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.73384050 |
| 30 | Ketoacidosis (HP:0001993) | 3.64111359 |
| 31 | Abnormality of nucleobase metabolism (HP:0010932) | 3.59795603 |
| 32 | Delayed CNS myelination (HP:0002188) | 3.50092392 |
| 33 | Abnormality of purine metabolism (HP:0004352) | 3.48526739 |
| 34 | Hypoalphalipoproteinemia (HP:0003233) | 3.48163140 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.46742818 |
| 36 | Abnormality of the intrinsic pathway (HP:0010989) | 3.42912921 |
| 37 | Abnormality of serum amino acid levels (HP:0003112) | 3.37343240 |
| 38 | Conjugated hyperbilirubinemia (HP:0002908) | 3.35437393 |
| 39 | Hyperbilirubinemia (HP:0002904) | 3.26978285 |
| 40 | Abnormality of complement system (HP:0005339) | 3.16718570 |
| 41 | Generalized aminoaciduria (HP:0002909) | 3.16619142 |
| 42 | Dicarboxylic aciduria (HP:0003215) | 3.09152029 |
| 43 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.09152029 |
| 44 | Metabolic acidosis (HP:0001942) | 3.08898798 |
| 45 | Steatorrhea (HP:0002570) | 3.06905273 |
| 46 | Lethargy (HP:0001254) | 3.02812876 |
| 47 | Hypercholesterolemia (HP:0003124) | 2.96916036 |
| 48 | Proximal tubulopathy (HP:0000114) | 2.87519477 |
| 49 | Hepatocellular carcinoma (HP:0001402) | 2.86493374 |
| 50 | Bile duct proliferation (HP:0001408) | 2.83528407 |
| 51 | Abnormal biliary tract physiology (HP:0012439) | 2.83528407 |
| 52 | Vascular calcification (HP:0004934) | 2.75684084 |
| 53 | Cerebral edema (HP:0002181) | 2.69532546 |
| 54 | Malnutrition (HP:0004395) | 2.67669848 |
| 55 | Increased purine levels (HP:0004368) | 2.67654055 |
| 56 | Hyperuricemia (HP:0002149) | 2.67654055 |
| 57 | Pancreatic cysts (HP:0001737) | 2.64588993 |
| 58 | Alkalosis (HP:0001948) | 2.59227111 |
| 59 | Spastic diplegia (HP:0001264) | 2.53691151 |
| 60 | Irritability (HP:0000737) | 2.51536846 |
| 61 | Abnormality of urine glucose concentration (HP:0011016) | 2.51114256 |
| 62 | Glycosuria (HP:0003076) | 2.51114256 |
| 63 | Spontaneous abortion (HP:0005268) | 2.48778745 |
| 64 | Increased serum pyruvate (HP:0003542) | 2.48048228 |
| 65 | Vomiting (HP:0002013) | 2.44535632 |
| 66 | Acute encephalopathy (HP:0006846) | 2.43291363 |
| 67 | Abnormality of the renal cortex (HP:0011035) | 2.42886677 |
| 68 | Cardiovascular calcification (HP:0011915) | 2.41134456 |
| 69 | Pancreatic fibrosis (HP:0100732) | 2.40300164 |
| 70 | Late onset (HP:0003584) | 2.38281070 |
| 71 | Myocardial infarction (HP:0001658) | 2.38185912 |
| 72 | Neonatal onset (HP:0003623) | 2.38144212 |
| 73 | True hermaphroditism (HP:0010459) | 2.36515812 |
| 74 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.36378157 |
| 75 | Abnormality of alanine metabolism (HP:0010916) | 2.36378157 |
| 76 | Hyperalaninemia (HP:0003348) | 2.36378157 |
| 77 | Hypoglycemic seizures (HP:0002173) | 2.35196784 |
| 78 | Hypochromic microcytic anemia (HP:0004840) | 2.33650563 |
| 79 | Enlarged kidneys (HP:0000105) | 2.32503306 |
| 80 | Arthropathy (HP:0003040) | 2.31487719 |
| 81 | Systemic lupus erythematosus (HP:0002725) | 2.31371674 |
| 82 | Pancreatitis (HP:0001733) | 2.25655822 |
| 83 | Skin nodule (HP:0200036) | 2.24823543 |
| 84 | Rickets (HP:0002748) | 2.24664730 |
| 85 | Reduced antithrombin III activity (HP:0001976) | 2.21843441 |
| 86 | Brushfield spots (HP:0001088) | 2.21720351 |
| 87 | Hypothermia (HP:0002045) | 2.20815561 |
| 88 | Sensorimotor neuropathy (HP:0007141) | 2.20003776 |
| 89 | Abnormal gallbladder morphology (HP:0012437) | 2.15937470 |
| 90 | Hydroxyprolinuria (HP:0003080) | 2.15265505 |
| 91 | Abnormality of proline metabolism (HP:0010907) | 2.15265505 |
| 92 | Opisthotonus (HP:0002179) | 2.14477873 |
| 93 | Cholecystitis (HP:0001082) | 2.13260592 |
| 94 | Abnormal gallbladder physiology (HP:0012438) | 2.13260592 |
| 95 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.11897732 |
| 96 | Cholelithiasis (HP:0001081) | 2.09143304 |
| 97 | Osteomalacia (HP:0002749) | 2.07687525 |
| 98 | Acute necrotizing encephalopathy (HP:0006965) | 2.06577932 |
| 99 | Potter facies (HP:0002009) | 2.05160912 |
| 100 | Facial shape deformation (HP:0011334) | 2.05160912 |
| 101 | Acanthocytosis (HP:0001927) | 2.04444695 |
| 102 | Abnormality of midbrain morphology (HP:0002418) | 2.03222493 |
| 103 | Molar tooth sign on MRI (HP:0002419) | 2.03222493 |
| 104 | Abnormality of glycolysis (HP:0004366) | 2.02152674 |
| 105 | Nausea (HP:0002018) | 2.00392083 |
| 106 | Glomerulonephritis (HP:0000099) | 1.99659008 |
| 107 | Chronic hepatic failure (HP:0100626) | 1.98752179 |
| 108 | Abnormal cartilage morphology (HP:0002763) | 1.97709688 |
| 109 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.96960247 |
| 110 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.96824093 |
| 111 | Fair hair (HP:0002286) | 1.96519044 |
| 112 | Mitral stenosis (HP:0001718) | 1.94291897 |
| 113 | Congenital stationary night blindness (HP:0007642) | 1.92300897 |
| 114 | Renal cortical cysts (HP:0000803) | 1.91322824 |
| 115 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.89566273 |
| 116 | Nephrolithiasis (HP:0000787) | 1.89425079 |
| 117 | Hypophosphatemic rickets (HP:0004912) | 1.87895702 |
| 118 | Mitochondrial inheritance (HP:0001427) | 1.87833751 |
| 119 | Lipid accumulation in hepatocytes (HP:0006561) | 1.86937024 |
| 120 | Increased CSF lactate (HP:0002490) | 1.86347050 |
| 121 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85760413 |
| 122 | Thrombophlebitis (HP:0004418) | 1.85313847 |
| 123 | Hepatic necrosis (HP:0002605) | 1.84413377 |
| 124 | Esophageal varix (HP:0002040) | 1.83848399 |
| 125 | Hyperphosphaturia (HP:0003109) | 1.82932903 |
| 126 | Elevated alkaline phosphatase (HP:0003155) | 1.82769873 |
| 127 | Gingival bleeding (HP:0000225) | 1.82305722 |
| 128 | Elevated hepatic transaminases (HP:0002910) | 1.81820634 |
| 129 | Abnormality of the gallbladder (HP:0005264) | 1.81065415 |
| 130 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.80652495 |
| 131 | Abnormality of vitamin metabolism (HP:0100508) | 1.79717800 |
| 132 | Renal Fanconi syndrome (HP:0001994) | 1.79324445 |
| 133 | Methylmalonic acidemia (HP:0002912) | 1.78163243 |
| 134 | Hemorrhage of the eye (HP:0011885) | 1.75488337 |
| 135 | Nephritis (HP:0000123) | 1.73732767 |
| 136 | Abnormal urine phosphate concentration (HP:0012599) | 1.71510304 |
| 137 | Pendular nystagmus (HP:0012043) | 1.70877965 |
| 138 | Retrobulbar optic neuritis (HP:0100654) | 1.70452790 |
| 139 | Optic neuritis (HP:0100653) | 1.70452790 |
| 140 | Increased hepatocellular lipid droplets (HP:0006565) | 1.69184111 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 8.10633954 |
| 2 | ERN1 | 3.84545954 |
| 3 | FGFR4 | 3.62941613 |
| 4 | ZAK | 3.54793660 |
| 5 | TAOK3 | 3.49991755 |
| 6 | TXK | 3.42776291 |
| 7 | ERBB4 | 3.37680707 |
| 8 | SIK1 | 3.32786528 |
| 9 | TRIM28 | 2.68940802 |
| 10 | STK38L | 2.66447509 |
| 11 | NUAK1 | 2.65296410 |
| 12 | BMPR1B | 2.53790553 |
| 13 | WNK4 | 2.52217536 |
| 14 | INSRR | 2.43281234 |
| 15 | TLK1 | 2.41600429 |
| 16 | ADRBK2 | 2.38456829 |
| 17 | WNK3 | 2.22899348 |
| 18 | GRK1 | 2.21525492 |
| 19 | FLT3 | 2.14906063 |
| 20 | MAP4K2 | 2.11354990 |
| 21 | LATS1 | 2.11330522 |
| 22 | PIK3CA | 2.06965606 |
| 23 | MAP3K4 | 1.92131065 |
| 24 | MAPK11 | 1.87923991 |
| 25 | BCR | 1.86408196 |
| 26 | VRK1 | 1.83699624 |
| 27 | MAP2K4 | 1.72299950 |
| 28 | MST1R | 1.71433065 |
| 29 | PKN2 | 1.71364651 |
| 30 | ABL2 | 1.70531751 |
| 31 | OXSR1 | 1.68136524 |
| 32 | MUSK | 1.63759439 |
| 33 | PINK1 | 1.63521187 |
| 34 | PIK3CG | 1.61384283 |
| 35 | CASK | 1.58360855 |
| 36 | SIK2 | 1.51104137 |
| 37 | MAP3K6 | 1.49910337 |
| 38 | PRKCG | 1.44280288 |
| 39 | MAPK13 | 1.42821080 |
| 40 | DYRK2 | 1.38841652 |
| 41 | TYK2 | 1.33248343 |
| 42 | NEK9 | 1.25617208 |
| 43 | VRK2 | 1.22304717 |
| 44 | TRIB3 | 1.14726428 |
| 45 | NEK1 | 1.14435196 |
| 46 | PRKAA2 | 1.09876713 |
| 47 | KDR | 1.07897996 |
| 48 | RIPK1 | 1.06035658 |
| 49 | STK16 | 1.04149929 |
| 50 | MAP2K3 | 1.01252782 |
| 51 | JAK2 | 1.00197634 |
| 52 | MAP3K3 | 0.97492024 |
| 53 | PDK4 | 0.92867726 |
| 54 | PDK3 | 0.92867726 |
| 55 | MAPK15 | 0.92827325 |
| 56 | PRKCE | 0.90690998 |
| 57 | GRK6 | 0.90268752 |
| 58 | ACVR1B | 0.89307981 |
| 59 | EIF2AK1 | 0.89226640 |
| 60 | PRKCI | 0.88214113 |
| 61 | PTK6 | 0.86830009 |
| 62 | MAP2K7 | 0.86390596 |
| 63 | MAP3K12 | 0.86380187 |
| 64 | FRK | 0.85460908 |
| 65 | PRKCQ | 0.81911387 |
| 66 | MAP3K7 | 0.80869613 |
| 67 | MET | 0.78555461 |
| 68 | PRKACA | 0.77851525 |
| 69 | IRAK3 | 0.76535184 |
| 70 | EPHA4 | 0.76438245 |
| 71 | MAP3K11 | 0.76242373 |
| 72 | NME1 | 0.75267291 |
| 73 | TNIK | 0.74357687 |
| 74 | MST4 | 0.73652470 |
| 75 | PRKAA1 | 0.72247415 |
| 76 | CAMKK2 | 0.71257309 |
| 77 | TIE1 | 0.70709001 |
| 78 | PLK3 | 0.70592486 |
| 79 | LATS2 | 0.69727674 |
| 80 | TYRO3 | 0.68536119 |
| 81 | MAP2K6 | 0.65928712 |
| 82 | TTK | 0.63879542 |
| 83 | MAPKAPK3 | 0.63706141 |
| 84 | MAPK4 | 0.63372680 |
| 85 | TBK1 | 0.62382797 |
| 86 | SGK223 | 0.61292113 |
| 87 | SGK494 | 0.61292113 |
| 88 | ERBB2 | 0.60644189 |
| 89 | PRKG1 | 0.59864904 |
| 90 | DYRK1B | 0.59718025 |
| 91 | NME2 | 0.59451855 |
| 92 | PRKCZ | 0.59327918 |
| 93 | PAK3 | 0.59316454 |
| 94 | BRSK2 | 0.59025711 |
| 95 | BRAF | 0.58815837 |
| 96 | ADRBK1 | 0.58656381 |
| 97 | IKBKB | 0.58069798 |
| 98 | ITK | 0.57291073 |
| 99 | GSK3A | 0.57040604 |
| 100 | CSNK1G1 | 0.55793880 |
| 101 | PBK | 0.53626521 |
| 102 | CSNK2A1 | 0.53489322 |
| 103 | FGFR3 | 0.53081315 |
| 104 | NTRK2 | 0.52831259 |
| 105 | MAP3K5 | 0.52774859 |
| 106 | MAPK12 | 0.51230017 |
| 107 | PRKACG | 0.49424909 |
| 108 | MAP3K14 | 0.48926168 |
| 109 | STK39 | 0.48899069 |
| 110 | CDK4 | 0.47506388 |
| 111 | PTK2 | 0.47173405 |
| 112 | EIF2AK3 | 0.46824943 |
| 113 | MAP3K13 | 0.46137851 |
| 114 | SGK2 | 0.45943825 |
| 115 | PRKCA | 0.45444779 |
| 116 | KSR2 | 0.44992364 |
| 117 | DAPK2 | 0.44363391 |
| 118 | DAPK1 | 0.44303545 |
| 119 | CSNK1D | 0.44007937 |
| 120 | DYRK3 | 0.43986051 |
| 121 | CAMK2G | 0.43823075 |
| 122 | CDK6 | 0.43741741 |
| 123 | SGK3 | 0.43070382 |
| 124 | RPS6KA5 | 0.41876289 |
| 125 | NEK2 | 0.41753695 |
| 126 | CAMK1 | 0.41727589 |
| 127 | PRKACB | 0.41629618 |
| 128 | PDK2 | 0.41568108 |
| 129 | EPHB2 | 0.41510945 |
| 130 | CDK8 | 0.41310049 |
| 131 | MOS | 0.39497077 |
| 132 | MAP3K10 | 0.38876110 |
| 133 | CSNK1E | 0.37115155 |
| 134 | ERBB3 | 0.36954308 |
| 135 | CSNK2A2 | 0.36352636 |
| 136 | PLK1 | 0.36257536 |
| 137 | JAK1 | 0.36222405 |
| 138 | MAP3K8 | 0.36002500 |
| 139 | STK3 | 0.35832403 |
| 140 | PRKCB | 0.35327700 |
| 141 | CSF1R | 0.33383182 |
| 142 | MAPKAPK5 | 0.33260902 |
| 143 | CSNK1G3 | 0.33042041 |
| 144 | PHKG1 | 0.32842855 |
| 145 | PHKG2 | 0.32842855 |
| 146 | FGFR1 | 0.32732870 |
| 147 | TAOK2 | 0.32555753 |
| 148 | TEC | 0.32188599 |
| 149 | EPHB1 | 0.31389166 |
| 150 | PDPK1 | 0.31262321 |
| 151 | TGFBR2 | 0.30937501 |
| 152 | IKBKE | 0.30651627 |
| 153 | MAP2K1 | 0.28568705 |
| 154 | MAP2K2 | 0.28252220 |
| 155 | PLK4 | 0.26388110 |
| 156 | MELK | 0.25043556 |
| 157 | IGF1R | 0.24612442 |
| 158 | MTOR | 0.24531431 |
| 159 | STK38 | 0.23385179 |
| 160 | CSK | 0.23222917 |
| 161 | FGFR2 | 0.22639636 |
| 162 | LRRK2 | 0.22638837 |
| 163 | CSNK1G2 | 0.19481631 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.15970871 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.56278813 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.07203745 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.94828260 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.82275102 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.77659610 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69559813 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.68758513 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.64938366 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50206625 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.43280278 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.41389503 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.29377843 |
| 14 | * Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.27600776 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.21344162 |
| 16 | * Peroxisome_Homo sapiens_hsa04146 | 2.18001128 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09555271 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.96572433 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90617131 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.85523124 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.83906196 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.81789460 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.79525960 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77562603 |
| 25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.75142349 |
| 26 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.71389776 |
| 27 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.69126698 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.68389406 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.68223738 |
| 30 | * Fatty acid metabolism_Homo sapiens_hsa01212 | 1.65691178 |
| 31 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.63717471 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.59188851 |
| 33 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.54035249 |
| 34 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.53500890 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.52475130 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.51032829 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.50290525 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.48940137 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.45822354 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.38563609 |
| 41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.34181988 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.31670051 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.30256774 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29875073 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29275380 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.27686413 |
| 47 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.19894143 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.16983857 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.14850589 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.14180546 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 1.09917779 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.04607787 |
| 53 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.03501708 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.01649741 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00882701 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 0.99024640 |
| 57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97968559 |
| 58 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.96020972 |
| 59 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.94871392 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.87859486 |
| 61 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.86957482 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.84920025 |
| 63 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.80566377 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79351594 |
| 65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72606522 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.67461732 |
| 67 | Parkinsons disease_Homo sapiens_hsa05012 | 0.64647326 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.57545864 |
| 69 | Proteasome_Homo sapiens_hsa03050 | 0.47687422 |
| 70 | Phototransduction_Homo sapiens_hsa04744 | 0.40074866 |
| 71 | RNA polymerase_Homo sapiens_hsa03020 | 0.39717663 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37934064 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36515202 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33646510 |
| 75 | Huntingtons disease_Homo sapiens_hsa05016 | 0.33544739 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.31781621 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.31507502 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.30895654 |
| 79 | Homologous recombination_Homo sapiens_hsa03440 | 0.30284796 |
| 80 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.26992050 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.26500998 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.25489443 |
| 83 | Alzheimers disease_Homo sapiens_hsa05010 | 0.25269533 |
| 84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.17604218 |
| 85 | RNA degradation_Homo sapiens_hsa03018 | 0.15891187 |
| 86 | Prion diseases_Homo sapiens_hsa05020 | 0.15172940 |
| 87 | Ribosome_Homo sapiens_hsa03010 | 0.14601307 |
| 88 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.13611822 |
| 89 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.12695040 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.12081744 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11457959 |
| 92 | Basal transcription factors_Homo sapiens_hsa03022 | 0.09736192 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.08677582 |
| 94 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.05641398 |
| 95 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.04259882 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.02650229 |
| 97 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.01637947 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.00529367 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | -0.2104043 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2088929 |
| 101 | Bladder cancer_Homo sapiens_hsa05219 | -0.2065501 |
| 102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2026294 |
| 103 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.1991668 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1916777 |
| 105 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1753843 |
| 106 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.1665227 |
| 107 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1593659 |
| 108 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0797286 |
| 109 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0725936 |
| 110 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0702188 |
| 111 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0681832 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0390855 |
| 113 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0389209 |
| 114 | Protein export_Homo sapiens_hsa03060 | -0.0264158 |
| 115 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0158145 |
| 116 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.0113068 |

